Unlock instant, AI-driven research and patent intelligence for your innovation.

Synthesis method of cefalonium impurity B

A kind of technology of ceflonine and synthesis method, applied in the synthesis field of ceflonine impurity B

Pending Publication Date: 2021-09-10
AMICOGEN CHINA BIOPHARM CO LTD
View PDF5 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

But because this cefaroning impurity is a specific impurity, and this impurity is rarely sold on the market, therefore based on this specific impurity, it has important value to the quality control and safety assessment of cefaroning medicine, so the research on the cefaroning impurity Synthesis has very important practical significance

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Synthesis method of cefalonium impurity B
  • Synthesis method of cefalonium impurity B
  • Synthesis method of cefalonium impurity B

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029] Dissolve 10.0g of cefalotin sodium (23.9mmol 1.0eq) in 75ml of water, stir at room temperature to dissolve, add 75ml of methanol, cool down to -20~-25°C, add triethylamine (23.9mmol 1.0eq), at -20~ After reacting at -25°C for 1 hour, transfer to 20~25°C and add 6 N HCl to quench the reaction, and adjust the pH to 4.0. Methanol was rotary evaporated, extracted with DCM, and the aqueous phase was lyophilized to obtain 9.6 g of crude product. Take 9.6g of the crude product and add 100ml of water to dissolve it, add 100ml of acetone dropwise, stir at 0~5°C, add 200ml of EA dropwise, and flocculent precipitates gradually appear. -5~0°C, stirred and grown the crystal for 1 hour, then filtered and dried with suction to obtain 7.5g of impurity B with a purity of 95.0%.

Embodiment 2

[0031] Dissolve 10.0g of cefalotin sodium (23.9mmol 1.0eq) in 75ml of water, stir at room temperature to dissolve, add 75ml of methanol, cool down to -35~-40℃, add triethylamine (23.9mmol 1.0eq), at -35~ After reacting at -40°C for 1 hour, transfer to 20~25°C and add 6 N HCl to quench the reaction, and adjust the pH to 4.0. Methanol was rotary evaporated, extracted with DCM, and the aqueous phase was lyophilized to obtain 9.3 g of crude product. Take 9.3g of the crude product and add 100ml of water to dissolve it, add 100ml of acetone dropwise, stir at 0~5°C, add 200ml of EA dropwise, gradually a flocculent precipitate appears. -5~0°C, stirred and grown the crystal for 1 hour, and dried with suction to obtain 7.1g of impurity B with a purity of 95.5%.

Embodiment 3

[0033] Dissolve 10.0g of cefalotin sodium (23.9mmol 1.0eq) in 75ml of water, stir at room temperature to dissolve, add 75ml of methanol, cool down to -20~-25℃, add sodium bicarbonate (23.9mmol 1.0eq), at -20~ After reacting at -25°C for 1 hour, transfer to 20~25°C and add 6 N HCl to quench the reaction, and adjust the pH to 4.5. Methanol was rotary evaporated, extracted with DCM, and the aqueous phase was lyophilized to obtain 9.5 g of crude product. Take 9.5g of the crude product and add 100ml of water to dissolve it, add 100ml of acetone dropwise, stir at 0~5°C, add 200ml of EA dropwise, gradually a flocculent precipitate appears. -5~0°C, stirred and grown the crystal for 1 hour, filtered and dried with suction to obtain 7.2g of impurity B with a purity of 95.2%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a synthesis method of a cefalonium impurity B. According to the synthesis method, initial raw materials are easy to obtain, and the impurity B is prepared from alkali in a polar solvent. The method is simple to operate, mild in reaction condition and high in yield, and the cost is greatly reduced. The synthesized cefalonium impurity B can be used as a reference substance for cefalonium detection, and has a certain promotion effect on deep research on safety, reliability and stability of related medication of cefalonium and quality control in the production process.

Description

technical field [0001] The invention relates to the technical field of organic synthesis, in particular to a method for synthesizing cefaroning impurity B. Background technique [0002] Molecular formula C of cefalonine 20 h 18 N 4 o 5 S 2 , the molecular weight is 458.51, the molecular structure is shown in figure 1 , the chemical name is (6R,7R)-3-[(4-carbamoylpyridin-1-ium-1-yl)methyl]-8-oxo-7-[(2-thiophen-2-ylacetyl )amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid inner salt, Chemical Abstracts (CAS) Accession No. 5575-21-3. [0003] Cefalonine, a cephalosporin antibiotic for animals developed by Schering-Plough Pharmaceutical Company of the United States, with a trade name of: Cepravin® Dry Cow, is an effective drug for preventing and treating mastitis in dry dairy cows, and has antibacterial properties. It has the advantages of broad spectrum, strong bactericidal power, less allergic reaction, and low toxicity, and has a good clinical application pr...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D501/04C07D501/56
CPCC07D501/04C07D501/56
Inventor 姜晓超闫伟汪娜杨慧娟方军李建国王玲
Owner AMICOGEN CHINA BIOPHARM CO LTD